Genomics Inform Search

CLOSE


Genomics Inform > Volume 5(2); 2007 > Article
Pharmacogenomics in Drug Discovery and Development.
Chul Ahn
Department of Medicine, University of Texas Medical School, Houston, TX 77030, USA. Chul.W.Ahn@uth.tmc.edu
Abstract
Pharmacogenomics is the study that examines how genetic variations affect the ways in which people respond to drugs. The ways people respond to drugs are complex traits that are influenced by many different genes. Pharmacogenomics intends to develop rational means of optimizing drug therapy, with respect to the patients' genotype, to maximize efficacy with minimal adverse drug reactions. Pharmacogenomics has the potential to revolutionize the practice of medicine, and promises to usher in an area of personalized medicine, in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Indeed, pharmacogenomics is exploited as an essential step for target discovery and drug development in the pharmaceutical industry. The goal of the personalized medicine is to get the right dose of the right drug to the right patient at the right time. In this article, we will review the use of pharmacogenomics in drug discovery and development.
Keywords: targeted therapy; theragnostics
TOOLS
Share :
Facebook Twitter Linked In Google+
METRICS Graph View
  • 1,026 View
  • 12 Download
Related articles in GNI

Data Mining for High Dimensional Data in Drug Discovery and Development.2003 December;1(2)



ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
Room No. 806, 193 Mallijae-ro, Jung-gu, Seoul 04501, Korea
Tel: +82-2-558-9394    Fax: +82-2-558-9434    E-mail: kogo3@kogo.or.kr                

Copyright © 2022 by Korea Genome Organization.

Developed in M2PI

Close layer
prev next